Get Real Time Here
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open20.920 | Close20.580 |
| Vol / Avg.760.121K / 1.722M | Mkt Cap1.232B |
| Day Range20.300 - 20.980 | 52 Wk Range16.515 - 59.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.550 | -2.680 | -0.1300 | ||||
| REV | 2.940M | 2.474M | -466.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | B of A Securities | Tazeen Ahmad | Maintains | NeutralNeutral | Lowers | 25.00 | 24.00 |
| 2023-09-07 | Mizuho | Vamil Divan | Maintains | NeutralNeutral | Raises | 19.00 | 20.00 |
| 2023-09-07 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 25.00 | 22.00 |
| 2023-08-09 | Goldman Sachs | Salveen Richter | Maintains | NeutralNeutral | Lowers | 75.00 | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SAGE | Sage Therapeutics | -0.68% | 1.2B |
| TWST | Twist Bioscience | -1.46% | 1.2B |
| ETNB | 89bio | 0% | 1.2B |
| ZNTL | Zentalis Pharma | 2.19% | 1.4B |
| SNDX | Syndax Pharmaceuticals | 7.04% | 1.2B |
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Who are Sage Therapeutics's (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Sage Therapeutics (SAGE) stock?
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by B of A Securities on Friday, September 8, 2023. The analyst firm set a price target for 24.00 expecting SAGE to rise to within 12 months (a possible 16.62% upside). 45 analyst firms have reported ratings in the last year.
Current Stock Price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $20.58 last updated September 29, 2023 at 8:20 PM UTC.
Does Sage Therapeutics (SAGE) pay a dividend?
There is no dividend information for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.